Results 261 to 270 of about 68,183 (284)

[Allogeneic adoptive immunotherapy].

Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine, 2003
Recognition of the importance of immune cells present in a hematopoietic graft has resulted in a significant change in the perception of allogeneic hematopoietic transplantation. Such a transplant modality is now perceived has a very efficient form of adoptive allogeneic immunotherapy unfortunately associated with significant toxicity.
P, Tiberghien, E, Robinet, C, Ferrand, P, Saas, P, Hervé   +4 more
openaire   +1 more source

ADOPTIVE IMMUNOTHERAPY

The Pediatric Infectious Disease Journal, 1999
J L, Hurwitz, K S, Slobod
openaire   +2 more sources

ADOPTIVE IMMUNOTHERAPY

The Lancet, 1989
openaire   +4 more sources

Adoptive immunotherapy

2011
Chrystal U. Heslop, Helen E. Louis
openaire   +2 more sources

[Adoptive immunotherapy of malignancies].

Vestnik Rossiiskoi akademii meditsinskikh nauk, 2008
The results of the studies show that mononuclear leukocytes isolated from human peripheral blood, malignant effusions, and surgically removed spleen can be generated into lymphokine-activated killers (LAK) characterized by high anti-tumor activity. LAKs may be used foradoptive immunotherapy of malignant effusions and the prevention of tumor recurrence ...
I Zh, Shubina, A G, Bliumenberg, S M, Volkov, L V, Demidov, M V, Kiselevskiĭ   +4 more
openaire   +1 more source

Adoptive Immunotherapy

2008
Chrystal U. Louis, Helen E. Heslop
openaire   +1 more source

Adoptive Immunotherapy

2004
Burkhard Ludewig, Matthias W. Hoffmann
openaire   +1 more source

Adoptive cellular immunotherapy

2006
Helen E. Heslop, Cliona M. Rooney
openaire   +2 more sources

Adoptive immunotherapy.

Cancer chemotherapy and biological response modifiers, 1994
M, Sznol, W J, Urba
openaire   +2 more sources

Adoptive Immunotherapy in Malignant Disease

Immunological Reviews, 1972
Thompson, R B, Mathe, G
openaire   +2 more sources